In 2018, an investigation by Kong et al. revealed that Portulaca extract could alleviate colitis in mice and mediate colonic cell apoptosis through inhibiting the NF-κB pathway with decreased expressions of bax and caspase-3 and increased expression of bcl-2 (Kong et al., 2018). The gene discussed is NFKB1; the disease is colitis.